recombinant single-domain antibody fragments (University of Calgary/Alberta Glycomics Centre)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug Namerecombinant single-domain antibody fragments (University of Calgary/Alberta Glycomics Centre)
Drug Alias NameClostridium difficile toxin A modulator (University of Calgary/Alberta Glycomics Centre)
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody fragmentBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionToxin A modulators
TargetsToxin A
Therapy Area/IndicationsDiarrheaColitisClostridium Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanada
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Calgary
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGlycomics Institute of AlbertaUniversity Of Calgary
Active IndicationsN/A
Inactive IndicationsDiarrheaColitisClostridium Infections

Other Information

ATC CodeN/A
Related LinksN/A